Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04772547 · ClinicalTrials.gov registry record · Phase 2
VIGABatrin in Post-anoxic STATus Epilepticus - Phase IIa
A Phase 2 study, sponsored by University of Florida.
- Completed
- Registry status
- Phase 2
- Development phase
- 6
- Enrollment target
NCT04772547 is a Phase 2 study that has completed, run by University of Florida. The registered enrollment target is 6 participants.
The verdict
NCT04772547, a Phase 2 study, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 6 participants
- Enrollment target
Study Summary
This is a pilot trial of a single loading dose of vigabatrin in post-anoxic status epilepticus.
Interventions
- DRUG Vigabatrin Only Product
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2021-09-22 |
| Est. Completion | 2024-01-23 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04772547
The ClinicalTrials.gov registry entry for NCT04772547 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Vigabatrin Only Product is the first listed.
NCT04772547 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04772547 about?
NCT04772547 is a clinical study titled "VIGABatrin in Post-anoxic STATus Epilepticus - Phase IIa". This is a pilot trial of a single loading dose of vigabatrin in post-anoxic status epilepticus.
What is the current status of trial NCT04772547?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 6 participants. The study started on 2021-09-22. Estimated completion is 2024-01-23.
What interventions are being tested in trial NCT04772547?
The interventions under investigation include: Vigabatrin Only Product (DRUG).
Who is sponsoring clinical trial NCT04772547?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.